rs139533994

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_000238.4(KCNH2):​c.558C>T​(p.Gly186Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000385 in 1,439,032 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. G186G) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0021 ( 2 hom., cov: 33)
Exomes 𝑓: 0.00018 ( 2 hom. )

Consequence

KCNH2
NM_000238.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.452

Publications

1 publications found
Variant links:
Genes affected
KCNH2 (HGNC:6251): (potassium voltage-gated channel subfamily H member 2) This gene encodes a component of a voltage-activated potassium channel found in cardiac muscle, nerve cells, and microglia. Four copies of this protein interact with one copy of the KCNE2 protein to form a functional potassium channel. Mutations in this gene can cause long QT syndrome type 2 (LQT2). Transcript variants encoding distinct isoforms have been identified. [provided by RefSeq, May 2022]
KCNH2 Gene-Disease associations (from GenCC):
  • long QT syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • long QT syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • short QT syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • short QT syndrome type 1
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • Brugada syndrome
    Inheritance: AD Classification: MODERATE, NO_KNOWN Submitted by: ClinGen, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 7-150958417-G-A is Benign according to our data. Variant chr7-150958417-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 200214.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.452 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00209 (317/151922) while in subpopulation AFR AF = 0.0072 (299/41504). AF 95% confidence interval is 0.00653. There are 2 homozygotes in GnomAd4. There are 148 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 317 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000238.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNH2
NM_000238.4
MANE Select
c.558C>Tp.Gly186Gly
synonymous
Exon 4 of 15NP_000229.1A0A090N8Q0
KCNH2
NM_001406753.1
c.270C>Tp.Gly90Gly
synonymous
Exon 2 of 13NP_001393682.1Q12809-7
KCNH2
NM_172056.3
c.558C>Tp.Gly186Gly
synonymous
Exon 4 of 9NP_742053.1Q12809-5

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNH2
ENST00000262186.10
TSL:1 MANE Select
c.558C>Tp.Gly186Gly
synonymous
Exon 4 of 15ENSP00000262186.5Q12809-1
KCNH2
ENST00000713710.1
c.558C>Tp.Gly186Gly
synonymous
Exon 4 of 15ENSP00000519013.1A0AAQ5BGR0
KCNH2
ENST00000713701.1
c.258C>Tp.Gly86Gly
synonymous
Exon 3 of 14ENSP00000519004.1A0AAQ5BGQ9

Frequencies

GnomAD3 genomes
AF:
0.00207
AC:
315
AN:
151814
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00718
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000787
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000589
Gnomad OTH
AF:
0.000959
GnomAD2 exomes
AF:
0.000217
AC:
12
AN:
55250
AF XY:
0.0000923
show subpopulations
Gnomad AFR exome
AF:
0.00740
Gnomad AMR exome
AF:
0.000576
Gnomad ASJ exome
AF:
0.000427
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000184
AC:
237
AN:
1287110
Hom.:
2
Cov.:
32
AF XY:
0.000159
AC XY:
101
AN XY:
633738
show subpopulations
African (AFR)
AF:
0.00652
AC:
166
AN:
25456
American (AMR)
AF:
0.000465
AC:
9
AN:
19348
Ashkenazi Jewish (ASJ)
AF:
0.0000949
AC:
2
AN:
21066
East Asian (EAS)
AF:
0.00
AC:
0
AN:
27990
South Asian (SAS)
AF:
0.00
AC:
0
AN:
66542
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
32330
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4048
European-Non Finnish (NFE)
AF:
0.0000280
AC:
29
AN:
1037232
Other (OTH)
AF:
0.000584
AC:
31
AN:
53098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
16
32
48
64
80
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00209
AC:
317
AN:
151922
Hom.:
2
Cov.:
33
AF XY:
0.00199
AC XY:
148
AN XY:
74282
show subpopulations
African (AFR)
AF:
0.00720
AC:
299
AN:
41504
American (AMR)
AF:
0.000786
AC:
12
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5130
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10508
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.0000589
AC:
4
AN:
67912
Other (OTH)
AF:
0.000949
AC:
2
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
16
32
48
64
80
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000601
Hom.:
0
Bravo
AF:
0.00238
Asia WGS
AF:
0.000290
AC:
1
AN:
3458

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)
-
-
1
Cardiovascular phenotype (1)
-
-
1
Long QT syndrome (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
3.4
DANN
Benign
0.91
PhyloP100
-0.45
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs139533994; hg19: chr7-150655505; API